Assessment of methodologic quality of randomized trials of interventional techniques: Development of an interventional pain management specific instrument

Pain Physician

Volumn 17, Issue 3, 2014, Pages 263-290

  Manchikanti, Laxmaiah ^a   Hirsch, Joshua A ^b   Cohen, Steven P ^c   Heavner, James E ^d   Falco, Frank J E ^e   Diwan, Sudhir ^f   Boswell, Mark V ^g   Candido, Kenneth D ^h   Onyewu, Obi ⁱ   Zhu, Jie ^j   Sehgal, Nalini ^k   Kaye, Alan D ^l   Benyamin, Ramsin M ^m   Helm, Standiford ⁿ   Singh, Vijay ^o   Datta, Sukdeb ^p   Abdi, Sala Hadin ^q   Christo, Paul J ^r   Hameed, Haroon ^s   Hameed, Mariam ^t   Vallejo, Ri Cardo ^u   Pampati, Vidyasagar ^a   Racz, Gabor B ^d   Prithvi Raj, P ^d   more..

^a PAIN MANAGEMENT CENTER OF PADUCAH   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^f TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^g Mid Atlantic Spine and Pain Physicians   (United States)

^h TEMPLE UNIVERSITY HOSPITAL   (United States)

ⁱ Manhattan Spine and Pain Medicine   (United States)

^j University of Louisville School of Medicine   (United States)

^k ADVOCATE ILLINOIS MASONIC MEDICAL CENTER   (United States)

^l UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^m LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

ⁿ MILLENNIUM PAIN CENTER   (United States)

^o UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^p The Helm Center for Pain Management   (United States)

^q Spine Pain Diagnostics Associates   (United States)

^r MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^s UNIVERSITY OF TEXAS   (United States)

^t Blaustein Pain Treatment Center   (United States)

^u Spine Care Center   (United States)

more..

Author keywords

Cochrane reviews; Comparative effectiveness research; Evidence based medicine; Interventional techniques; Methodological quality assessment; Risk of bias assessment

Indexed keywords

ANALGESIA; ARTICLE; CLINICAL PRACTICE; COCHRANE LIBRARY; COMPARATIVE EFFECTIVENESS; EVALUATION STUDY; EVIDENCE BASED MEDICINE; HEALTH CARE CONCEPTS; HUMAN; INTERVENTION STUDY; MEASUREMENT ACCURACY; MEDICAL DEVICE; METHODOLOGY; OUTCOME ASSESSMENT; PATIENT CARE; PRACTICE GUIDELINE; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; VALIDATION STUDY; EARLY INTERVENTION; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCIBILITY; STANDARDS;

EARLY MEDICAL INTERVENTION; HUMANS; PAIN MANAGEMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS;

EID: 84901258145     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (249)

1. Manchikanti L, Falco FJE, Singh V, Be- nyamin RM, Racz GB, Helm II S, Cara- way DL, Calodney AK, Snook LT, Smith HS, Gupta S, Ward SP, Grider JS, Hirsch JA. An update of comprehensive evidence-based guidelines for interventional techniques of chronic spinal pain. Part I: Introduction and general consider-ations. Pain Physician 2013; 16:S1-S48.
2. Manchikanti L, Abdi S, Atluri S, Benya-Min RM, Boswell MV, Buenaventura RM, Bryce DA, Burks PA, Caraway DL, Calod-Ney AK, Cash KA, Christo PJ, Cohen SP, Colson J, Conn A, Cordner HJ, Couba-Rous S, Datta S, Deer TR, Diwan SA, Fal- co FJE, Fellows B, Geffert SC, Grider JS, Gupta S, Hameed H, Hameed M, Han- En H, Helm II S, Janata JW, Justiz R, Kaye AD, Lee M, Manchikanti KN, McM-Anus CD, Onyewu O, Parr AT, Patel VB, Racz GB, Sehgal N, Sharma M, Simo-Poulos TT, Singh V, Smith HS, Snook LT, Swicegood J, Vallejo R, Ward SP, Wargo BW, Zhu J, Hirsch JA. An update of com- prehensive evidence-based guidelines for interventional techniques of chronic spinal pain: Part II: Guidance and recom- mendations. Pain Physician 2013; 16:S49- S283.
3. Gagliardi AR, Brouwers MC. Integrat-ing guideline development and imple- mentation: Analysis of guideline devel- opment manual instructions for gener- ating implementation advice. Implement Sci 2012; 7:67.
4. Manchikanti L, Benyamin RM, Fal-Co FJE, Caraway DL, Datta S, Hirsch JA. Guidelines warfare over interventional techniques: Is there a lack of discourse or straw man? Pain Physician 2012; 15:E1- E26.
5. Manchikanti L, Helm II S, Hirsch JA. The evolution of the Patient-Centered Out- come Research Institute. J Neurointer- vent Surg 2012; 4:157-162.
6. Manchikanti L, Hirsch JA. The Indepen- dent Payment Advisory Board: Impact on neurointerventionalists. J Neurointerv Surg 2012; 4:468-472.
7. U.S. Department of Health and Human Services Agency for Healthcare Research and Quality (AHRQ). www.ahrq.gov
8. Loblaw DA, Prestrud AA, Somerfield MR, Oliver TK, Brouwers MC, Nam RK, Lyman GH, Basch E. American Society of Clinical Oncology Clinical Practice Guidelines: Formal systematic review- based consensus methodology. J Clin Oncol 2012; 30:3136-3140.
9. Turner L, Shamseer L, Altman DG, Weeks L, Peters J, Kober T, Dias S, Schulz KF, Plint AC, Moher D. Con- solidated standards of reporting tri- als (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical jour- nals. Cochrane Database Syst Rev 2012; 11:MR000030.
10. Greene JA, Jones DS, Podolsky SH. Ther- apeutic evolution and the challenge of rational medicine. N Engl J Med 2012; 367:1077-1082.
11. Chan AW, Tetzlaff JM, Altman DG, Lau- pacis A, Gøtzsche PC, Krleža-Jerić K, Hróbjartsson A, Mann H, Dickersin K, Berlin JA, Doré CJ, Parulekar WR, Sum- merskill WS, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D. SPIRIT 2013 statement: Defining stan- dard protocol items for clinical trials. Ann Intern Med 2013; 158:200-207.
12. Graham R, Mancher M, Wolman DM, Greenfield S, Steinberg E (eds); Commit- tee on Standards for Developing Trust- worthy Clinical Practice Guidelines; Insti- tute of Medicine. Clinical Practice Guide- lines We Can Trust. The National Acade- mies Press, Washington, DC, 2011.
13. Eden J, Levit L, Berg A, Morton S (eds); Committee on Standards for Systematic Reviews of Comparative Effectiveness Research; Institute of Medicine. Finding What Works in Health Care. Standards for Systematic Reviews. The National Acade- mies Press, Washington, DC, 2011.
14. Chang SM, Bass EB, Berkman N, Car- ey TS, Kane RL, Lau J, Ratichek S. Chal- lenges in implementing The Institute of Medicine systematic review standards. Syst Rev 2013; 2:69.
15. Young BK, Greenberg PB. Are the In- stitute of Medicine's trustworthiness guidelines trustworthy? R I Med J Au- gust 2013; 96:13-14.
16. Verhagen AP, de Vet HCW, de Bie RA, Kessels AGH, Boers M, Bouter LM, Knipschild PG. The Delphi list: A cri- teria list for quality assessment of ran- domized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 1998; 51:1235-1241.
17. Jadad AR, Moore RA, Carroll D, Jenkin- son C, Reynolds DJM, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996; 17:1-12.
18. Moher D, Jadad AR, Nichol G, Penman M, Tugwell P, Walsh S. Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin Trials 1995; 16:62- 73.
19. Sherrington C, Herbert RD, Maher CG, Moseley AM. PEDro. A database of randomized trials and systematic reviews in physiotherapy. Man Ther 2000; 5:223- 226.
20. West S, King V, Carey TS, Lohr KN, McK- oy N, Sutton SF, Lux L. Systems to Rate the Strength of Scientific Evidence. Ev- idence Report/Technology Assessment No. 47. AHRQ Publication No. 02-E016. Rockville, MD: Agency for Healthcare Research and Quality, 2002.
21. Furlan AD, Pennick V, Bombardier C, van Tulder M; Editorial Board, Cochrane Back Review Group. 2009 up- dated method guidelines for system- atic reviews in the Cochrane Back Re- view Group. Spine (Phila Pa 1976) 2009; 34:1929-1941.
22. Marin TJ, Furlan AD, Bombardier C, van Tulder M; Editorial Board of the Cochrane Back Review Group. Fifteen years of the Cochrane Back Review Group. Spine (Phila Pa 1976) 2013; 38:2057-2063.
23. Chan AW, Tetzlaff JM, Gøtzsche PC, Alt- man DG, Mann H, Berlin JA, Dickersin K, Hróbjartsson A, Schulz KF, Parulekar WR, Krleza-Jeric K, Laupacis A, Moher D. SPIRIT 2013 explanation and elabo- ration: guidance for protocols of clinical trials. BMJ 2013; 346:e7586.
24. Bafeta A, Trinquart L, Seror R, Ravaud P. Analysis of the systematic reviews pro- cess in reports of network meta-analy- ses: Methodological systematic review. BMJ 2013; 347:f3675.
25. Kirkham JJ, Gargon E, Clarke M, Wil- liamson PR. Can a core outcome set im- prove the quality of systematic reviews?- -a survey of the Co-ordinating Editors of Cochrane Review Groups. Trials 2013; 14:21.
26. Smith V, Devane D, Begley CM, Clarke M. Methodology in conducting a sys- tematic review of systematic reviews of healthcare interventions. BMC Med Res Methodol 2011; 11:15.
27. Bambra C. Real world reviews: A begin- ner's guide to undertaking systemat- ic reviews of public health policy inter- ventions. J Epidemiol Community Health 2011; 65:14-19.
28. Henderson LK, Craig JC, Willis NS, Tovey D, Webster AC. How to write a Cochrane systematic review. Nephrology (Carlton) 2010; 15:617-624.
29. Murthy L, Shepperd S, Clarke MJ, Gar- ner SE, Lavis JN, Perrier L, Roberts NW, Straus SE. Interventions to improve the use of systematic reviews in decision- making by health system managers, policy makers and clinicians. Cochrane Database Syst Rev 2012; 9:CD009401.
30. Harker J, Kleijnen J. What is a rapid review? A methodological exploration of rapid reviews in Health Technology Assessments. Int J Evid Based Healthc 2012; 10:397-410.
31. Watt A, Cameron A, Sturm L, Lathlean T, Babidge W, Blamey S, Facey K, Hailey D, Norderhaug I, Maddern G. Rapid re- views versus full systematic reviews: An inventory of current methods and prac- tice in health technology assessment. Int J Technol Assess Health Care 2008; 24:133-139. Erratum in: Int J Technol As- sess Health Care 2008; 24:369.
32. Gagnier JJ, Kellam PJ. Reporting and methodological quality of systematic reviews in the orthopaedic literature. J Bone Joint Surg Am 2013; 95:e771-e777.
33. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: The QUO-ROM statement. Quality of reporting of metanalyses. Lancet 1999; 354:1896-1900.
34. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting sys- tematic reviews and meta-analyses of studies that evaluate health care inter- ventions: Explanation and elaboration. Ann Intern Med 2009; 151:W65-W94.
35. Chou R, Huffman L. Guideline for the Evaluation and Management of Low Back Pain: Evidence Review. American Pain So- ciety, Glenview, IL, 2009. www.americanpainsociety.org/up-loads/pdfs/LBPEvidRev.pdf
36. Pinto RZ, Maher CG, Ferreira ML, Han- cock M, Oliveira VC, McLachlan AJ, Koes B, Ferreira PH. Epidural corticosteroid injections in the management of sciat- ica: A systematic review and meta-analy- sis. Ann Intern Med 2012; 157:865-877.
37. Staal JB, de Bie RA, de Vet HC, Hildeb- randt J, Nelemans P. Injection therapy for subacute and chronic low back pain: An updated Cochrane review. Spine (Phi- la Pa 1976) 2009; 34:49-59.
38. Nelemans PJ, Debie RA, DeVet HC, Sturmans F. Injection therapy for sub- acute and chronic benign low back pain. Spine (Phila Pa 1976) 2001; 26:501-515.
39. Chou R, Atlas SJ, Loeser JD, Rosen- quist RW, Stanos SP. Guideline warfare over interventional therapies for low back pain: Can we raise the level of dis- course? J Pain 2011; 12:833-839.
40. Niemistö L, Kalso E, Malmivaara A, Seit- salo S, Hurri H. Radiofrequency dener- vation for neck and back pain: A sys- tematic review within the framework of the Cochrane Collaboration Back Re- view Group. Spine (Phila Pa 1976) 2003; 28:1877-1888.
41. van Tulder MW, Assendelft WJ, Koes BW, Bouter LM. Method guidelines for sys- tematic reviews in the Cochrane col- laboration back review group for spi- nal disorders. Spine (Phila Pa 1976) 1997; 22:2323-2330.
42. van Tulder M, Furlan A, Bombardier C, Bouter L; Editorial Board of the Cochrane Collaboration Back Review Group. Updated method guidelines for systematic reviews in the Cochrane collaboration back review group. Spine (Phila Pa 1976) 2003; 28:1290-1299.
43. Armijo-Olivo S, Fuentes J, Rogers T, Hartling L, Saltaji H, Cummings GG. How should we evaluate the risk of bias of physical therapy trials?: A psychomet- ric and meta-epidemiological approach towards developing guidelines for the design, conduct, and reporting of RCTs in Physical Therapy (PT) area: A study protocol. Syst Rev 2013; 2:88.
44. Pildal J, Hrobjartsson A, Jorgensen KJ, Hilden J, Altman DG, Gotzsche PC. Im- pact of allocation concealment on con- clusions drawn from metaanalyses of randomized trials. Int J Epidemiol 2007; 36:847-857.
45. Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG, Gluud C, Martin RM, Wood AJG, Sterne JAC. Empirical ev- idence of bias in treatment effect esti- mates in controlled trials with different interventions and outcomes: Meta-epi- demiological study. BMJ 2008; 336:601-605.
46. Hartling L, Ospina M, Liang Y, Dryden DM, Hooton N, Seida JK, Klassen TP. Risk of bias versus quality assessment of randomized controlled trials: Cross sec- tional study. BMJ 2009; 339:1017.
47. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Klassen TP. Does quality of reports of random- ized trials affect estimates of interven- tion efficacy reported in meta-analyses? Lancet 1998; 352:609-613.
48. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: Dimen- sions of methodological quality associ- ated with estimates of treatment effects in controlled trials. JAMA 1995; 273:408- 412.
49. Berger VW, Weinstein S. Ensuring the comparability of comparison groups: Is randomization enough? Control Clin Tri- als 2004; 25:515-524.
50. Trowman R, Dumville JC, Torgerson DJ, Cranny G. The impact of trial baseline imbalances should be considered in sys- tematic reviews: A methodological case study. J Clin Epidemiol 2007; 60:1229-1233.
51. Hewitt CE, Kumaravel B, Dumville JC, Torgerson DJ. Assessing the impact of attrition in randomized controlled trials. J Clin Epidemiol 2010; 63:1264-1270.
52. Nuesch E, Trelle S, Reichenbach S, Rutjes AWS, Burgi E, Scherer M, Altman DG, Juni P. The effects of excluding pa- tients from the analysis in randomized controlled trials: Meta-epidemiological study. BMJ 2009; 339:679-683.
53. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: A systematic re- view. JAMA 2003; 289:454-465.
54. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: Sys- tematic review. BMJ 2003; 326:1167-1170.
55. Kjaergard LL, Als-Nielsen B. Associa- tion between competing interests and authors' conclusions: Epidemiological study of randomized clinical trials pub- lished in the BMJ. BMJ 2002; 325:249-252.
56. Armijo-Olivo S, Macedo LG, Gadotti IC, Fuentes J, Stanton T, Magee DJ. Scales to assess the quality of randomized con- trolled trials: A systematic review. Phys Ther 2008; 88:156-175.
57. Colle F, Rannou F, Revel M, Fermanian J, Poiraudeau S. Impact of quality scales on levels of evidence inferred from a systematic review of exercise therapy and low back pain. Arch Phys Med Reha- bil 2002; 83:1745-1752.
58. Herbison P, Hay-Smith J, Gillespie WJ. Adjustment of meta-analyses on the basis of quality scores should be aban- doned. J Clin Epidemiol 2006; 59:1249-1256.
59. Armijo-Olivo S, Stiles C, Hagen N, Bi-Ondo P, Cummings G. Assessment of study quality for systematic reviews: A comparison of the Cochrane collab- oration risk of bias tool and the effec- tive public health practice project qual- ity assessment tool: Methodological re- search. J Eval Clin Pract 2012; 18:12-18. The Cochrane Library, 2013, Issue 4.
60. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, Guyatt GH, Harbour RT, Haugh MC, Henry D, Hill S, Jaeschke R, Leng G, Liberati A, Magrini N, Mason J, Middleton P, Mrukowicz J, O'Connell D, Oxman AD, Phillips B, Schünemann HJ, Edejer TT, Varonen H, Vist GE, Williams JW Jr, Zaza S; GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004; 328:1490.
61. van Tulder MW, Suttorp M, Morton S, Bouter LM, Shekelle P. Empirical evi- dence of an association between inter- nal validity and effect size in random- ized controlled trials low-back pain. Spine (Phila Pa 1976) 2009; 34:1685-1692.
62. Murray MR, Wang T, Schroeder GD, Hsu WK. The 100 most cited spine ar- ticles. Eur Spine J 2012; 21:2059-2069.
63. Hartling L, Hamm MP, Milne A, Van- dermeer B, Santaguida PL, Ansari M, Tsertsvadze A, Hempel S, Shekelle P, Dryden DM. Testing the risk of bias tool showed low reliability between individ- ual reviewers and across consensus as-sessments of reviewer pairs. J Clin Epi- demiol 2013; 66:973-981.
64. Altman DG, Schulz KF, Moher D, Egg- er M, Davidoff F, Elbourne D, Gøtzsche PC, Lang T; CONSORT GROUP (Consolidated Standards of Reporting Trials). The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med 2001; 134:663-694.
65. Moher D, Hopewell S, Schulz KF, Mon- tori V, Gøtzsche PC, Devereaux PJ, El- bourne D, Egger M, Altman DG. CON- SORT 2010 explanation and elaboration: Updated guidelines for reporting paral- lel group randomised trials. BMJ 2010; 340:c869.
66. Moher D. CONSORT: An evolving tool to help improve the quality of reports of randomized controlled trials. Con- solidated Standards of Reporting Trials. JAMA 1998; 279:1489-491.
67. A proposal for structured reporting of randomized controlled trials. The Stan- dards of Reporting Trials Group. JAMA 1994; 272:1926-1931.
68. [No authors listed]. Call for comments on a proposal to improve reporting of clinical trials in the biomedical litera- ture. Working Group on Recommen- dations for Reporting of Clinical Trials in the Biomedical Literature. Ann Intern Med 1994; 121:894-895.
69. Rennie D. Reporting randomized con- trolled trials. An experiment and a call for responses from readers. JAMA 1995; 273:1054-1055.
70. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF. Improv- ing the quality of reporting of random- ized controlled trials: The CONSORT statement. JAMA 1996; 276:637-639.
71. Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M, STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration. Ann Intern Med 2007; 147:W163-W194.
72. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Li- jmer JG, Moher D, Rennie D, de Vet HC; Standards for Reporting of Diagnostic Accuracy. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Ann In- tern Med 2003; 138:40-44.
73. Whiting P, Rutjes A, Reitsma J, Bossuyt P, Kleijnen J. The Development of QUA-DAS: A tool for the quality assessment of studies of diagnostic accuracy includ- ed in systematic reviews. BMC Med Res Methodol 2003; 3:25.
74. Lucas NP, Macaskill P, Irwing L, Bog- duk N. The development of a quality ap- praisal tool for studies of diagnostic re- liability (QAREL). J Clin Epidemiol 2010; 63:854-861.
75. Rennie D. CONSORT revised-improv- ing the reporting of randomized trials. JAMA 2001; 285:2006-2007.
76. Centers for Disease Control and Pre- vention. Transparent Reporting of Eval- uations with Non-randomized Designs (TREND). The TREND Statement. http://www.cdc.gov/trendstatement/
77. Dick FD, Graveling RA, Munro W, Walk- er-Bone K; Guideline Development Group. Workplace management of up- per limb disorders: A systematic review. Occup Med (Lond) 2011; 61:19-25.
78. Ghogomu EA, Maxwell LJ, Buchbinder R, Rader T, Pardo Pardo J, Johnston RV, Christensen RD, Rutjes AW, Winzenberg TM, Singh JA, Zanoli G, Wells GA, Tug- well P. Updated Method Guidelines for Cochrane Musculoskeletal Group Sys- tematic Reviews and Metaanalyses. J Rheumatol 2014; 41:194-205.
79. Jüni P, Altman DG, Egger M. Systemat- ic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001; 323:42-46.
80. Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, Porter AC, Tugwell P, Moher D, Bouter LM. Devel- opment of AMSTAR: A measurement tool to assess the methodological qual- ity of systematic reviews. BMC Med Res Methodol 2007; 7:10.
81. Tetzlaff JM, Chan AW, Kitchen J, Samp- son M, Tricco A, Moher D. Guidelines for randomized clinical trial protocol content: A systematic review. Syst Rev 2012; 1:43.
82. Getz KA, Zuckerman R, Cropp AB, Hin- dle AL, Krauss R, Kaitin KI. Measuring the incidence, causes, and repercus- sions of protocol amendments. Drug Inf J 2011; 45:265-275.
83. Hopewell S, Dutton S, Yu LM, Chan AW, Altman DG. The quality of reports of randomised trials in 2000 and 2006: Comparative study of articles indexed in PubMed. BMJ 2010; 340:c723.
84. Moher D, Schulz KF, Simera I, Altman DG. Guidance for developers of health research reporting guidelines. PLoS Med 2010; 7:1000217.
85. Bicket M, Gupta A, Brown CH, Cohen SP. Epidural injections for spinal pain: A systematic review and meta-analysis evaluating the "control" injections in randomized controlled trials. Anesthesi- ology 2013; 119:907-931.
86. Colle F, Poiraudeau S, Revel M. Critical analysis of a systematic review of the lit- erature and a meta-analysis on exercise therapy and chronic low back pain. Ann Readapt Med Phys 2001; 44:221-233.
87. Whiting P, Harbord R, Kleijnen J. No role for quality scores in systematic re- views of diagnostic accuracy studies. BMC Med Res Methodol 2005; 5:19.
88. Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clini- cal trials for meta-analysis. JAMA 1999; 282:1054-1060.
89. Assessing risk of bias in included stud- ies. In: Higgins JPT, Green S (eds). Co- chrane Handbook for Systematic Reviews of Interventions. The Cochrane Collabo- ration, 2008.
90. Koes BW, Scholten RJ, Mens JMA, Bout-Er LM. Epidural steroid injections for low back pain and sciatica. An updated systematic review of randomized clinical trials. Pain Digest 1999; 9:241-247.
91. Koes BW, Scholten RJ, Mens JM, Bout-Er LM. Efficacy of epidural steroid injec- tions for low-back pain and sciatica: A systematic review of randomized clinical trials. Pain 1995; 63:279-288.
92. Karjalainen K, Malmivaara A, van Tul- der M, Roine R, Jauhiainen M, Hurri H, Koes B. Multidisciplinary biopsychoso- cial rehabilitation for neck and shoul- der pain among working age adults: A systematic review within the framework of the Cochrane Collaboration Back Re- view Group. Spine (Phila Pa 1976) 2001; 26:174-181.
93. Furlan AD, Brosseau L, Imamura M, Ir- vin E. Massage for low-back pain: A sys- tematic review within the framework of the Cochrane Collaboration Back Re- view Group. Spine (Phila Pa 1976) 2002; 27:1896-1910.
94. Desmeules F, Côté CH, Frémont P. Therapeutic exercise and orthopedic manual therapy for impingement syn- drome: A systematic review. Clin J Sport Med 2003; 13:176-182.
95. Furlan AD, Imamura M, Dryden T, Ir-Vin E. Massage for low back pain: An updated systematic review within the framework of the Cochrane Back Re- view Group. Spine (Phila Pa 1976) 2009; 34:1669-1684.
96. Kent P, Mjøsund HL, Petersen DH. Does targeting manual therapy and/or exer- cise improve patient outcomes in non- specific low back pain? A systematic re- view. BMC Med 2010; 8:22.
97. Rubinstein SM, van Middelkoop M, Kui- jpers T, Ostelo R, Verhagen AP, de Boer MR, Koes BW, van Tulder MW. A sys- tematic review on the effectiveness of complementary and alternative medi- cine for chronic non-specific low-back pain. Eur Spine J 2010; 19:1213-1228.
98. Hashimoto R, Dettori JR, Henrikson NB, Kercher L., Chou R. Health Tech- nology Assessment, Washington State Health Care Authority. Spinal Cord Stim- ulation. Spectrum Research, Inc., July 23, 2010. http://www.hta.hca.wa.gov/docu_ments/scs_072310_report_final.pdf
99. Shrout PE, Fleiss JL. Intraclass correla- tions: Uses in assessing rater reliability. Psychol Bulle 1979; 86:420-428.
100. Viera AJ, Garrett JM. Understanding in- terobserver agreement: The kappa sta- tistic. Fam Med 2005; 37:360-363.
101. Iversen T, Solberg TK, Romner B, Wils- gaard T, Twisk J, Anke A, Nygaard O, Hasvold T, Ingebrigtsen T. Effect of cau- dal epidural steroid or saline injection in chronic lumbar radiculopathy: Multi- centre, blinded, randomised controlled trial. BMJ 2011; 343:d5278.
102. Manchikanti L, Cash KA, Pampati V, Wargo BW, Malla Y. A randomized, dou- ble-blind, active control trial of fluoro- scopic cervical interlaminar epidural in- jections in chronic pain of cervical disc herniation: Results of a 2-year follow-up. Pain Physician 2013; 16:465-478.
103. Carette S, Leclaire R, Marcoux S, Mo- rin F, Blaise GA, St-Pierre A, Truchon R, Parent F, Levesque J, Bergeron V, Mont- miny P, Blanchette C. Epidural cortico- steroid injections for sciatica due to her- niated nucleus pulposus. N Engl J Med 1997; 336:1634-1640.
104. Dilke TFW, Burry HC, Grahame R. Ex- tradural corticosteroid injection in man- agement of lumbar nerve root compres- sion. Brit Med J 1973; 2:635-637.
105. Carette S, Marcoux S, Truchon R, Gron- din C, Gagnon J, Allard Y, Latulippe M. A controlled trial of corticosteroid in- jections into facet joints for chronic low back pain. N Engl J Med 1991; 325:1002-1007.
106. Ackerman WE 3rd, Ahmad M. The effica-cy of lumbar epidural steroid injections in patients with lumbar disc herniations. Anesth Analg 2007; 104:1217-1222.
107. Wilson-MacDonald J, Burt G, Griffin D, Glynn C. Epidural steroid injection for nerve root compression: A random- ized, controlled trial. J Bone Joint Surg Br 2005; 87-B:352-355.
108. Manchikanti L, Cash KA, McManus CD, Damron KS, Pampati V, Falco FJE. A ran- domized, double-blind controlled trial of lumbar interlaminar epidural injec-tions in central spinal stenosis: 2-year follow-up. Int J Phys Med Rehab 2014; in press.
109. Veldhuyzen van Zanten SJ, Cleary C, Tal- ley NJ, Peterson TC, Nyren O, Bradley LA, Verlinden M, Tytgat GN. Drug treat- ment of functional dyspepsia: A system- atic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol 1996; 91:660- 673.
110. Talley NJ, Owen BK, Boyce P, Paterson K. Psychological treatments for irrita- ble bowel syndrome: A critique of con- trolled treatment trials. Am J Gastroen- terol 1996; 91:277-283.
111. Kjaergard LL, Nikolova D, Gluud C. Ran- domized clinical trials in HEPATOLOGY: Predictors of quality. Hepatology 1999; 30:1134-1138.
112. Hall JC, Hill D, Watts JM. Misuse of sta- tistical methods in the Australasian sur- gical literature. Aust N Z J Surg 1982; 52:541-543.
113. Altman DG. Statistics in medical jour- nals. Stat Med 1982;1:59-71.
114. Pocock SJ, Hughes MD, Lee RJ. Statisti- cal problems in the reporting of clinical trials. A survey of three medical journals. N Engl J Med 1987; 317:426-432.
115. Altman DG. The scandal of poor medical research. BMJ 1994; 308:283-284.
116. World Health Organization. Internation- al Clinical Trials Registry Platform (IC- TRP). 2007. www.who.int/entity/ictrp/en/
117. International Conference on Harmon- isation of Technical Requirements for Registration of Pharmaceuticals for Hu- man Use. ICH Harmonised Tripartite Guideline. Choice of Control Group and Related Issues in Clinical Trials E10. July 20, 2000.
118. Manchikanti L, Singh V, Falco FJE, Cash KA, Pampati V. Evaluation of lumbar fac- et joint nerve blocks in managing chron- ic low back pain: A randomized, double- blind, controlled trial with a 2-year fol- low-up. Int J Med Sci 2010; 7:124-135.
119. Manchikanti L, Singh V, Falco FJE, Cash KA, Fellows B. Comparative outcomes of a 2-year follow-up of cervical me- dial branch blocks in management of chronic neck pain: A randomized, dou- ble-blind controlled trial. Pain Physician 2010; 13:437-450.
120. Manchikanti L, Singh V, Falco FJE, Cash KA, Pampati V, Fellows B. The role of thoracic medial branch blocks in man- aging chronic mid and upper back pain: A randomized, double-blind, active- control trial with a 2-year follow-up. An- esthesiol Res Pract 2012; 2012:585806.
121. Manchikanti L, Cash KA, McManus CD, Pampati V. Fluoroscopic caudal epidural injections in managing chronic axial low back pain without disc herniation, radic- ulitis or facet joint pain. J Pain Res 2012; 5:381-390.
122. Manchikanti L, Singh V, Cash KA, Pam- pati V, Damron KS, Boswell MV. Effect of fluoroscopically guided caudal epi- dural steroid or local anesthetic injec- tions in the treatment of lumbar disc herniation and radiculitis: A random- ized, controlled, double blind trial with a two-year follow-up. Pain Physician 2012; 15:273-286.
123. Manchikanti L, Singh V, Cash KA, Pam- pati V, Datta S. Fluoroscopic caudal epi- dural injections in managing post lum- bar surgery syndrome: Two-year results of a randomized, double-blind, active- control trial. Int J Med Sci 2012; 9:582-591.
124. Manchikanti L, Cash KA, McManus CD, Pampati V, Fellows B. Results of 2-year follow-up of a randomized, double- blind, controlled trial of fluoroscopic caudal epidural injections in central spi- nal stenosis. Pain Physician 2012; 15:371- 384.
125. Manchikanti L, Cash KA, Pampati V, Malla Y. Two-year follow-up results of fluoroscopic cervical epidural injections in chronic axial or discogenic neck pain: A randomized, double-blind, controlled trial. Int J Med Sci 2014; 11:309-320.
126. Manchikanti L, Malla Y, Cash KA, McM- anus CD, Pampati V. Fluoroscopic epi- dural injections in cervical spinal steno- sis: Preliminary results of a randomized, double-blind, active control trial. Pain Physician 2012; 15:E59-E70.
127. Manchikanti L, Malla Y, Cash KA, McM- anus CD, Pampati V. Fluoroscopic cer- vical interlaminar epidural injections in managing chronic pain of cervical post- surgery syndrome: Preliminary results of a randomized, double-blind active control trial. Pain Physician 2012; 15:13-26.
128. Manchikanti L, Singh V, Cash KA, Pam- pati V, Falco FJE. A randomized, double- blind, active-control trial of the effec- tiveness of lumbar interlaminar epidur- al injections in disc herniation. Pain Phy- sician 2014; 17:E61-E74.
129. Manchikanti L, Cash KA, McManus CD, Pampati V, Benyamin RM. A random- ized, double-blind, active-controlled trial of fluoroscopic lumbar interlami- nar epidural injections in chronic axial or discogenic low back pain: Results of a 2-year follow-up. Pain Physician 2013; 16:E491-E504.
130. Manchikanti L, Cash KA, McManus CD, Damron KS, Pampati V, Falco FJE. Lum- bar interlaminar epidural injections in central spinal stenosis: Preliminary re- sults of a randomized, double-blind, active control trial. Pain Physician 2012; 15:51-63.
131. Manchikanti L, Cash KA, McManus CD, Pampati V, Benyamin RM. A preliminary report of a randomized double-blind, active controlled trial of fluoroscopic thoracic interlaminar epidural injections in managing chronic thoracic pain. Pain Physician 2010; 13:E357-E369.
132. Manchikanti L, Cash KA, McManus CD, Pampati V, Benyamin RM. Assessment of thoracic interlaminar epidural in- jections in managing chronic thoracic pain: A randomized, double-blind, con- trolled trial with a 2-year follow-up. Reg Anesth Pain Med 2014; in submission.
133. Chou R, Loeser JD, Owens DK, Rosen- quist RW, Atlas SJ, Baisden J, Carragee EJ, Grabois M, Murphy DR, Resnick DK, Stanos SP, Shaffer WO, Wall EM; Ameri- can Pain Society Low Back Pain Guide- line Panel. Interventional therapies, surgery, and interdisciplinary rehabil- itation for low back pain: An evidence- based clinical practice guideline from the American Pain Society. Spine (Phila Pa 1976) 2009; 34: 1066-1077.
134. Manchikanti L, Datta S, Gupta S, Mung- lani R, Bryce DA, Ward SP, Benyamin RM, Sharma ML, Helm II S, Fellows B, Hirsch JA. A critical review of the Ameri- can Pain Society clinical practice guide- lines for interventional techniques: Part 2. Therapeutic interventions. Pain Physi- cian 2010; 13:E215-E264.
135. Tachihara H, Sekiguchi M, Kikuchi S, Konno S. Do corticosteroids produce additional benefit in nerve root infiltra- tion for lumbar disc herniation. Spine (Phila Pa 1976) 2008; 33:743-747.
136. Sato C, Sakai A, Ikeda Y, Suzuki H, Saka- moto A. The prolonged analgesic effect of epidural ropivacaine in a rat model of neuropathic pain. Anesth Analg 2008; 106:313-320.
137. Pasqualucci A. Experimental and clinical studies about the preemptive analgesia with local anesthetics. Possible reasons of the failure. Minerva Anestesiol 1998; 64:445-457.
138. Arner S, Lindblom U, Meyerson BA, Mo- lander C. Prolonged relief of neuralgia after regional anesthetic block. A call for further experimental and systemat- ic clinical studies. Pain 1990; 43:287-297.
139. Lavoie PA, Khazen T, Filion PR. Mech- anisms of the inhibition of fast axonal transport by local anesthetics. Neuro- pharmacology 1989; 28:175-181.
140. Cassuto J, Sinclair R, Bonderovic M. An- ti-inflammatory properties of local an- esthetics and their present and poten- tial clinical implications. Acta Anaesthe- siol Scand 2006; 50:265-282.
141. Pasqualucci A, Varrassi G, Braschi A, Peduto VA, Brunelli A, Marinangeli F, Gori F, Colò F, Paladín A, Mojoli F. Epi- dural local anesthetic plus corticoste- roid for the treatment of cervical brachi- al radicular pain: Single injection verus continuous infusion. Clin J Pain 2007; 23:551-557.
142. Hróbjartsson A, Kaptchuk TJ, Miller FG. Placebo effect studies are susceptible to response bias and to other types of bias- es. J Clin Epidemiol 2011; 64:1223-1229.
143. Wells RE, Kaptchuk TJ. To tell the truth, the whole truth, may do patients harm: The problem of the nocebo effect for in- formed consent. Am J Bioeth 2012; 12:22-29.
144. Howick J, Bishop FL, Heneghan, Wol-Stenholme J, Stevens S, Hobbs FDR, Lewith G. Placebo use in the United Kingdom: Results from a national sur- vey of primary care practitioners. PLOS One 2013; 8:e58247.
145. Howick J, Friedemann C, Tsakok M, Watson R, Tsakok T, Thomas J, Perera R, Fleming S, Heneghan C. Are treatments more effective than placebos? A system- atic review and meta-analysis. PLoS One 2013; 8:e62599.
146. Manchikanti L, Pampati V, Damron KS. The role of placebo and nocebo ef- fects of perioperative administration of sedatives and opioids in interventional pain management. Pain Physician 2005; 8:349-355.
147. Manchikanti L, Giordano J, Fellows B, Hirsch JA. Placebo and nocebo in inter- ventional pain management: A friend or a foe - or simply foes? Pain Physician 2011; 14:E157-E175.
148. Pham Dang C, Lelong A, Guilley J, Nguyen JM, Volteau C, Venet G, Perrier C, Lejus C, Blanloeil Y. Effect on neuro- stimulation of injectates used for peri- neural space expansion before place- ment of a stimulating catheter: Normal saline versus dextrose 5% in water. Reg Anesth Pain Med 2009; 34:398-403.
149. Tsui BC, Kropelin B, Ganapathy S, Finu- cane B. Dextrose 5% in water: Fluid me- dium maintaining electrical stimulation of peripheral nerve during stimulating catheter placement. Acta Anaesthesiol Scand 2005; 49:1562-1565.
150. Indahl A, Kaigle AM, Reikeräs O, Holm SH. Interaction between the porcine lumbar intervertebral disc, zygapophysi- al joints, and paraspinal muscles. Spine (Phila Pa 1976) 1997; 22:2834-2840.
151. Indahl A, Kaigle A, Reikerås O, Holm S. Electromyographic response of the por- cine multifidus musculature after nerve stimulation. Spine (Phila Pa 1976) 1995; 20:2652-2658.
152. Livingston EH, McNutt RA. The hazards of evidence-based medicine: Assessing variations in care. JAMA 2011; 306:762-763.
153. Karppinen J, Malmivaara A, Kurunlahti M, Kyllönen E, Pienimäki T, Nieminen P, Ohinmaa A, Tervonen O, Vanharanta H. Periradicular infiltration for sciatica: A randomized controlled trial. Spine (Ph- ila Pa 1976) 2001; 26:1059-1067.
154. Health Technology Assessment, Wash- ington State Health Care Authority. Spi- nal Injections, Updated Final Evidence Report. Spectrum Research, Inc., March 10, 2011. www.hta.hca.wa.gov/docu-ments/updated_final_report_spinal_in-jections_0310-1.pdf
155. Health Technology Assessment, Wash- ington State Health Care Authority. Spi- nal fusion for treatment of degenerative disc disease affecting the lumbar spine. Washington Health Technology Assess- ment. Rockville, MD; Agency for Health- care Research and Quality, 2006.
156. Health Technology Assessment, Wash- ington State Health Care Authority. Facet Neurotomy. Draft Evidence Re- port. Spectrum Research, Inc., Decem-ber 2, 2013. http://www.hca.wa.gov/hta/ Documents/facet_neurotomy_draft_re-port_121613.pdf
157. Ghahreman A, Ferch R, Bogduk N. The efficacy of transforaminal injection of steroids for the treatment of lumbar radicular pain. Pain Med 2010; 11:1149-1168.
158. Gerdesmeyer L, Wagenpfeil S, Birken- maier C, Veihelmann A, Hauschild M, Wagner K, Al Muderis M, Gollwitzer H, Diehl P, Toepfer A. Percutaneous epi- dural lysis of adhesions in chronic lum- bar radicular pain: A randomized dou- ble-blind placebo controlled trial. Pain Physician 2013; 16:185-196.
159. Arden NK, Price C, Reading I, Stubbing J, Hazelgrove J, Dunne C, Michel M, Rogers P, Cooper C, WEST Study Group. A multicentre randomized controlled trial of epidural corticosteroid injections for sciatica: The WEST study. Rheumatol- ogy (Oxford) 2005; 44:1399-1406.
160. MacVicar J, Borowczyk JM, MacVicar AM, Loughnan BM, Bogduk N. Lum- bar medial branch radiofrequency neu- rotomy in New Zealand. Pain Med 2013; 14:639-645.
161. Cohen SP, Bicket MC, Jamison D, Wilkinson I, Rathmell JP. Epidural ste- roids: A comprehensive, evidence-based review. Reg Anesth Pain Med 2013; 38:175-200.
162. Manchikanti L, Cash KA, McManus CD, Pampati V. Assessment of effectiveness of percutaneous adhesiolysis in manag- ing chronic low back pain secondary to lumbar central spinal canal stenosis. Int J Med Sci 2013; 10:50-59.
163. Manchikanti L, Singh V, Cash KA, Pam- pati V, Datta S. Assessment of effective- ness of percutaneous adhesiolysis and caudal epidural injections in managing lumbar post surgery syndrome: A 2-year follow-up of randomized, controlled tri- al. J Pain Res 2012; 5:597-608.
164. Manchikanti L, Benyamin RM, Falco FJ, Kaye AD, Hirsch JA. Do epidural injec- tions provide short- and long-term re- lief for lumbar disc herniation? A sys- tematic review. Clin Orthop Relat Res 2014 Feb 11. [Epub ahead of print].
165. Brenner L, Marhofer P, Kettner SC, Willschke H, Machata AM, Al-Zoraigi U, Lundblad M, Lönnqvist PA. Ultrasound assessment of cranial spread during caudal blockade in children: The effect of different volumes of local anaesthet- ics. Br J Anaesth 2011; 107:229-235.
166. Peng PW, Narouze S. Ultrasound-guid- ed interventional procedures in pain medicine: A review of anatomy, sono- anatomy, and procedures: Part I: Nonax- ial structures. Reg Anesth Pain Med 2009; 34:458-474.
167. Narouze S, Peng PW. Ultrasound-guid- ed interventional procedures in pain medicine: A review of anatomy, sono- anatomy, and procedures. Part II: Axi-al structures. Reg Anesth Pain Med 2010; 35:386-396.
168. Peng PW, Cheng P. Ultrasound-guided interventional procedures in pain med- icine: A review of anatomy, sonoanato- my, and procedures. Part III: Shoulder. Reg Anesth Pain Med 2011; 36:592-605.
169. Yoon JS, Sim KH, Kim SJ, Kim WS, Koh SB, Kim BJ. The feasibility of color Dop- pler ultrasonography for caudal epidural steroid injection. Pain 2005; 118:210-214.
170. Huang J. Disadvantages of ultrasound guidance in caudal epidural needle placement. Anesthesiology 2005; 102:693; Author's reply 693-694.
171. Chen CP, Tang SF, Hsu TC, Tsai WC, Liu HP, Chen MJ, Date E, Lew HL. Ul- trasound guidance in caudal epidural needle placement. Anesthesiology 2004; 101:181-184.
172. Bui J, Bogduk N. A systematic review of the effectiveness of CT-guided, lum- bar transforaminal injection of steroids. Pain Med 2013; 14:1860-1865.
173. Atluri S, Glaser SE, Shah RV, Sudarsha G. Needle position analysis in cases of paralysis from transforaminal epidurals: Consider alternative approaches to tra- ditional techniques. Pain Physician 2013; 16:321-334.
174. Smith-Bindman R, Lipson J, Marcus R, Kim KP, Mahesh M, Gould R, Ber- rington de González A, Miglioretti DL. Radiation dose associated with com- mon computed tomography examina- tions and the associated lifetime attrib- utable risk of cancer. Arch Intern Med 2009; 169:2078-2086.
175. Berrington de González A, Mahesh M, Kim KP, Bhargavan M, Lewis R, Met- tler F, Land C. Projected cancer risks from computed tomographic scans per- formed in the United States in 2007. Arch Intern Med 2009; 169:2071-2077.
176. Redberg RF. Cancer risks and radiation exposure from computed tomographic scans: How can we be sure that the ben- efits outweigh the risks? Arch Intern Med 2009; 169:2049-2050.
177. Abdul Latif L, Daud Amadera JE, Pimen- tel D, Pimentel T, Fregni F. Sample size calculation in physical medicine and re- habilitation: A systematic review of re- porting, characteristics, and results in randomized controlled trials. Arch Phys Med Rehabil 2011; 92:306-315.
178. Kumar R. Sample size calculation. Indi- an J Ophthalmol 2012; 60:582; discussion 582.
179. Simon EG, Fouché CJ, Perrotin F. Sam-ple size calculation in randomized trials: What the clinician needs to know. Gyne- col Obstet Fertil 2012; 40:629-630.
180. Ayeni O, Dickson L, Ignacy TA, Thoma A. A systematic review of power and sam- ple size reporting in randomized con- trolled trials within plastic surgery. Plast Reconstr Surg 2012; 130:78e-86e.
181. Lord SM, Barnsley L, Wallis BJ, McDon- ald GJ, Bogduk N. Percutaneous radio- frequency neurotomy for chronic cer- vical zygapophyseal-joint pain. N Engl J Med 1996; 335:1721-1726.
182. Van Kleef M, Barendse GA, Kessels A, Voets HM, Weber WE, de Lange S. Ran- domized trial of radiofrequency lumbar facet denervation for chronic low back pain. Spine (Phila Pa 1976) 1999; 24:1937-1942.
183. Manchikanti L, Pampati S, Cash KA. Making sense of the accuracy of diag- nostic lumbar facet joint nerve blocks: An assessment of implications of 50% relief, 80% relief, single block or con- trolled diagnostic blocks. Pain Physician 2010; 13:133-143.
184. Derby R, Melnik I, Lee JE, Lee SH. Cor- relation of lumbar medial branch neu- rotomy results with diagnostic medial branch block cutoff values to optimize therapeutic outcome. Pain Med 2012; 13:1533-1546.
185. Derby R, Melnik I, Choi J, Lee JE. In- dications for repeat diagnostic medial branch nerve blocks following a failed first medial branch nerve block. Pain Physician 2013; 16:479-488.
186. Cohen SP, Williams KA, Kurihara C, Nguyen C, Shields C, Kim P, Griffith SR, Larkin TM, Crooks M, Williams N, Mor- lando B, Strassels SA. Multicenter, ran- domized, comparative cost-effective- ness study comparing 0, 1, and 2 diag- nostic medial branch (facet joint nerve) block treatment paradigms before lum- bar facet radiofrequency denervation. Anesthesiology 2010; 113:395-405.
187. Falco FJE, Manchikanti L, Datta S, Se- hgal N, Geffert S, Onyewu O, Singh V, Bryce DA, Benyamin RM, Simopoulos TT, Vallejo R, Gupta S, Ward SP, Hirsch JA. An update of the systematic assess- ment of the diagnostic accuracy of lum- bar facet joint nerve blocks. Pain Physi- cian 2012; 15:E869-E907.
188. Falco FJE, Datta S, Manchikanti L, Seh- gal N, Geffert S, Singh V, Smith HS, Bo- swell MV. An updated review of diag- nostic utility of cervical facet joint injec- tions. Pain Physician 2012; 15:E807-E838.
189. Manchikanti L, Cash KA, Malla Y, Pam-pati V, Fellows B. A prospective evalu- ation of psychotherapeutic and illic- it drug use in patients presenting with chronic pain at the time of initial evalu- ation. Pain Physician 2013; 16:E1-E13.
190. National Government Services, Inc. LCD for Pain Management (L28529). Effective Date 01/01/2009.
191. Cigna Government Services. LCD for Pain Management (L31845). Revision Ef- fective Date: 01/01/2012.
192. Palmetto GBA. Local Coverage De- termination (LCD): Paravertebral Fac- et Joint Block (L31716). Effective Date: 03/19/2011.
193. Noridian Administrative Services. Lo- cal Coverage Determination (LCD) for Lumbar Facet Blockade (L30807). Effec- tive Date: 06/15/2011.
194. Chou R, Huffman L. Guideline for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain: Evidence Review. Amer- ican Pain Society, Glenview, IL, 2009. www.americanpainsociety.org/uploads/pdfs/Opioid_Final_Evidence_Report.pdf
195. Manchikanti L, Abdi S, Atluri S, Balog CC, Benyamin RM, Boswell MV, Brown KR, Bruel BM, Bryce DA, Burks PA, Bur-Ton AW, Calodney AK, Caraway DL, Cash KA, Christo PJ, Damron KS, Datta S, Deer TR, Diwan S, Eriator I, Falco FJE, Fellows F, Geffert S, Gharibo CG, Gla- ser SE, Grider JS, Hameed H, Hameed M, Hansen H, Harned ME, Hayek SM, Helm II S, Hirsch JA, Janata JW, Kaye AD, Kaye AM, Kloth DS, Koyyalagunta D, Lee M, Malla Y, Manchikanti KN, McMa- nus CD, Pampati V, Parr AT, Pasupule- ti R, Patel VB, Sehgal N, Silverman SM, Singh V, Smith HS, Snook LT, Solan- ki DR, Tracy DH, Vallejo R, Wargo BW. American Society of Interventional Pain Physicians (ASIPP) guidelines for re- sponsible opioid prescribing in chronic non-cancer pain: Part 2 - Guidance. Pain Physician 2012; 15:S67-S116.
196. Okoro CA, Zhao G, Li C, Balluz LS. Use of complementary and alternative med- icine among USA adults with function- al limitations: For treatment or general use? Complement Ther Med 2011; 19:208-215.
197. Okoro CA, Zhao G, Li C, Balluz LS. Has the use of complementary and alterna- tive medicine therapies by U.S. adults with chronic disease-related functional limitations changed from 2002 to 2007? J Altern Complement Med 2013; 19:217-223.
198. Sharma R, Haas M, Stano M, Spegman A, Gehring R. Determinants of costs and pain improvement for medical and chi- ropractic care of low back pain. J Manip- ulative Physiol Ther 2009; 32:252-261.
199. Zodet MW, Stevans JM. The 2008 preva- lence of chiropractic use in the US adult population. J Manipulative Physiol Ther 2012; 35:580-588.
200. Stevans JM, Zodet MW. Clinical, demo- graphic, and geographic determinants of variation in chiropractic episodes of care for adults using the 2005 - 2008 medical expenditure panel survey. J Ma- nipulative Physiol Ther 2012; 35:589-599.
201. Davis MA, Sirovich BE, Weeks WB. Uti- lization and expenditures on chiroprac- tic care in the United States from 1997 to 2006. Health Serv Res 2010; 45:748-761.
202. Machlin SR, Chevan J, Yu WW, Zodet MW. Determinants of utilization and expenditures for episodes of ambulato- ry physical therapy among adults. Phys Ther 2011; 91:1018-1029.
203. van Middelkoop M, Rubinstein SM, Kui- jpers T, Verhagen AP, Ostelo R, Koes BW, van Tulder MW. A systematic review on the effectiveness of physical and reha- bilitation interventions for chronic non- specific low back pain. Eur Spine J 2011; 20:19-39.
204. Fritz JM, Childs JD, Wainner RS, Fly- nn TW. Primary care referral of patients with low back pain to physical thera- py: Impact on future health care utiliza- tion and costs. Spine (Phila Pa 1976) 2012; 37:2114-2121.
205. Allen RP, Chen C, Garcia-Borreguero D, Polo O, DuBrava S, Miceli J, Knapp L, Winkelman JW. Comparison of prega- balin with pramipexole for restless legs syndrome. N Engl J Med 2014; 370:621-631.
206. Manchikanti L, Helm II S, Singh V, Hirsch JA. Accountable intervention- al pain management: A collaboration among practitioners, patients, payers, and government. Pain Physician 2013; 16:E635-E670.
207. Carragee EJ. The rise and fall of the "minimum clinically important differ-ence." Spine J 2010; 10:283-284.
208. Gatchel RJ, Mayer TG, Choi Y, Chou R. Validation of a consensus-based min- imal clinically important difference (MCID) threshold using an objective functional external anchor. Spine J 2013; 13:889-893.
209. Copay AG, Subach BR, Glassman SD, Polly DW Jr, Schuler TC. Understanding the minimum clinically important dif- ference: A review of concepts and meth-ods. Spine J 2007; 7:541-546.
210. Copay AG, Martin MM, Subach BR, Carreon LY, Glassman SD, Schuler TC, Berven S. Assessment of spine surgery outcomes: Inconsistency of change amongst outcome measurements. Spine J 2010; 10:291-296.
211. Gatchel R, Mayer TG. Testing minimal clinically important difference: Consen- sus or conundrum? Spine J 2010; 10:321- 327.
212. Parker SL, Adogwa O, Mendenhall SK, Shau DN, Anderson WN, Cheng JS, Devin CJ, McGirt MJ. Determination of minimum clinically important dif- ference (MCID) in pain, disability, and quality of life after revision fusion for symptomatic pseudoarthrosis. Spine J 2012; 12:1122-1128.
213. Deyo RA, Battie M, Beurskens AJ, Bom- bardier C, Croft P, Koes B, Malmivaara A, Roland M, Von Korff M, Waddell G. Outcome measures for low back pain research. A proposal for standardized use. Spine (Phila Pa 1976) 1998; 23:2003-2013.
214. Bombardier C. Outcome assessments in the evaluation of treatment of spi- nal disorders: Summary and general recommendations. Spine (Phila Pa 1976) 2000; 25:3100-3103.
215. Ostelo RW, Deyo RA, Stratford P, Wad- dell G, Croft P, Von Korff M, Bout- er LM, de Vet HC. Interpreting change scores for pain and functional status in low back pain: Towards internation- al consensus regarding minimal impor- tant change. Spine (Phila Pa 1976) 2008; 33:90-94.
216. Manchikanti L, Pampati V. Research de- signs in interventional pain manage- ment: Is randomization superior, desir- able or essential? Pain Physician 2002; 5:275-284.
217. Noordin S, Wright JG, Howard A. Rela- tionship between declared funding sup- port and level of evidence. J Bone Joint Surg Am 2010; 92:1647-1651.
218. Di Pietrantonj C, Demicheli V. Conflict of interest in industry-funded medical research. Epidemiol Prev 2005; 29:85-95.
219. Amiri AR, Kanesalingam K, Cro S, Casey AT. Does source of funding and conflict of interest influence the outcome and quality of spinal research? Spine J 2014; 14:308-314.
220. Fu R, Selph S, McDonagh M, Peterson K, Tiwari A, Chou R, Helfand M. Effec- tiveness and harms of recombinant hu- man bone morphogenetic protein-2 in spine fusion: A systematic review and meta-analysis. Ann Intern Med 2013; 158:890-902.
221. Bero L. Industry sponsorship and re- search outcome: A Cochrane review. JAMA Intern Med 2013; 173:580-581.
222. Peura PK, Martikainen JA, Purmonen TT, Turunen JH. Sponsorship-relat- ed outcome selection bias in published economic studies of triptans: Systemat- ic review. Med Decis Making 2012; 32:237- 245.
223. Sinyor M, Schaffer A, Smart KA, Lev-Itt AJ, Lanctôt KL, Grysman NH. Spon- sorship, antidepressant dose, and out- come in major depressive disorder: me- ta-analysis of randomized controlled tri- als. J Clin Psychiatry 2012; 73:e277-e287.
224. Jinapriya D, Anraku A, Alasbali T, Trope GE, Buys YM. Evaluation of investiga- tor bias in industry-funded clinical trials of latanoprost. Can J Ophthalmol 2011; 46:531-536.
225. Bhandari M, Busse JW, Jackowski D, Montori VM, Schünemann H, Sprague S, Mears D, Schemitsch EH, Heels-An-Sdell D, Devereaux PJ. Association be- tween industry funding and statistical- ly significant pro-industry findings in medical and surgical randomized trials. CMAJ 2004; 170:477-480.
226. Dunn AG, Mandl KD, Coiera E, Bour- geois FT. The effects of industry spon- sorship on comparator selection in tri- al registrations for neuropsychiatric conditions in children. PLoS One 2013; 8:e84951.
227. Gasparyan AY, Ayvazyan L, Akazha- nov NA, Kitas GD. Conflicts of interest in biomedical publications: Consider- ations for authors, peer reviewers, and editors. Croat Med J 2013; 54:600-608.
228. Lundh A, Barbateskovic M, Hróbjarts- son A, Gøtzsche PC. Conflicts of interest at medical journals: The influence of in- dustry-supported randomised trials on journal impact factors and revenue - co- hort study. PLoS Med 2010; 7:e1000354.
229. Khan NA, Lombeida JI, Singh M, Spen- cer HJ, Torralba KD. Association of in- dustry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthri- tis. Arthritis Rheum 2012; 64:2059-2067.
230. Kaiser KA, Cofield SS, Fontaine KR, Glasser SP, Thabane L, Chu R, Ambrale S, Dwary AD, Kumar A, Nayyar G, Affu- so O, Beasley M, Allison DB. Is funding source related to study reporting quality in obesity or nutrition randomized con- trol trials in top-tier medical journals? Int J Obes (Lond) 2012; 36:977-981.
231. Public Law No: 111-148: H.R. 3590. Pa- tient Protection and Affordable Care Act. March 23, 2010.
232. Physician Financial Transparency Re- ports (Sunshine Act). American Medical Association. August 1, 2013.
233. van den Boogaard E, Hermens RP, Franssen AM, Doornbos JP, Kremer JA, van der Veen F, Goddijn M. Recurrent miscarriage: Do professionals adhere to their guidelines. Hum Reprod 2013; 28:2898-2904.
234. Dipaola CP, Dea N, Dvorak MF, Lee RS, Hartig D, Fisher CG. Surgeon-indus- try conflict of interest: survey of opin- ions regarding industry-sponsored edu- cational events and surgeon teaching. J Neurosurg Spine 2014; 20:313-321.
235. Norris SL, Holmer HK, Ogden LA, Bur- da BU, Fu R. Conflicts of interest among authors of clinical practice guidelines for glycemic control in type 2 diabetes mellitus. PLoS One 2013; 8:e75284.
236. Neumann I, Akl EA, Valdes M, Bra- vo S, Araos S, Kairouz V, Schünemann H, Guyatt GH. Low anonymous vot- ing compliance with the novel poli- cy for managing conflicts of interest implemented in the 9th version of the American College of Chest Physicians antithrombotic guidelines. Chest 2013; 144:1111-1116.
237. Sah S, Loewenstein G. Nothing to de-clare: Mandatory and voluntary disclo- sure leads advisors to avoid conflicts of interest. Psychol Sci 2014; 25:575-584.
238. Hunsinger M, Smith SM, McKeown A, Parkhurst M, Gross RA, Lin AH, Mc- Dermott MP, Rappaport BA, Turk DC, Dworkin RH. Disclosure of authorship contributions in analgesic clinical trials and related publications: ACTTION sys- tematic review and recommendations. Pain 2013 [Epub ahead of print].
239. Korn D, Carlat D. Conflicts of interest in medical education: Recommendations from the Pew task force on medical con- flicts of interest. JAMA 2013; 310:2397-2398.
240. Feuerstein JD, Gifford AE, Akbari M, Goldman J, Leffler DA, Sheth SG, Cheif- etz AS. Systematic analysis underlying the quality of the scientific evidence and conflicts of interest in gastroenterology practice guidelines. Am J Gastroenterol 2013; 108:1686-1693.
241. Leopold SS, Beadling L, Dobbs MB, Gebhardt MC, Lotke PA, Rimnac CM, Wongworawat MD. Active management of financial conflicts of interest on the Editorial Board of CORR. Clin Orthop Relat Res 2013; 471:3393-3394.
242. Owens B. US conflict-of-interest case draws attention across continent. CMAJ 2013; 185:1309.
243. Kesselheim AS, Robertson CT, Myers JA, Rose SL, Gillet V, Ross KM, Glynn RJ, Jof- fe S, Avorn J. A randomized study of how physicians interpret research funding disclosures. N Engl J Med 2012; 367:1119-1127.
244. Lo B, Ott C. What is the enemy in CME, conflicts of interest or bias? JAMA 2013; 310:1019-1020.
245. Shader RI, Greenblatt DJ. The sunshine act. J Clin Psychopharmacol 2014; 34:1-2.
246. Sismondo S. Key opinion leaders and the corruption of medical knowledge: What the Sunshine Act will and won't cast light on. J Law Med Ethics 2013; 41:635-643.
247. Neumann I, Karl R, Rajpal A, Akl EA, Guyatt GH. Experiences with a novel policy for managing conflicts of interest of guideline developers: A descriptive qualitative study. Chest 2013; 144:398-404.
248. Cosgrove L, Bursztajn HJ, Erlich DR, Wheeler EE, Shaughnessy AF. Conflicts of interest and the quality of recom- mendations in clinical guidelines. J Eval Clin Pract 2013; 19:674-681.
249. Schofferman JA, Eskay-Auerbach ML, Sawyer LS, Herring SA, Arnold PM, Muehlbauer EJ. Conflict of interest and professional medical associations: The North American Spine Society experi- ence. Spine J 2013; 13:974-979.